Skip to main page content

. 2018 Nov;18(11):e445-e447.

doi: 10.1016/j.clml.2018.06.020. Epub 2018 Jun 27.

Clinical Activity of Pralatrexate in Patients With Cutaneous T-Cell Lymphoma Treated With Varying Doses of Pralatrexate

Francine M Foss¹, Terri L Parker², Michael Girardi³, Anlong Li⁴

Affiliations

Affiliations

¹ Department of Hematology, Yale University School of Medicine, New Haven, CT. Electronic address: francine.foss@yale.edu.
² Department of Hematology, Yale University School of Medicine, New Haven, CT.
³ Department of Dermatology, Yale University School of Medicine, New Haven, CT.
⁴ Yale University School of Medicine, New Haven, CT.

PMID: 30181105
DOI: 10.1016/j.clml.2018.06.020

Clinical Activity of Pralatrexate in Patients With Cutaneous T-Cell Lymphoma Treated With Varying Doses of Pralatrexate

Francine M Foss et al. Clin Lymphoma Myeloma Leuk. 2018 Nov.

. 2018 Nov;18(11):e445-e447.

doi: 10.1016/j.clml.2018.06.020. Epub 2018 Jun 27.

Authors

Francine M Foss¹, Terri L Parker², Michael Girardi³, Anlong Li⁴

Affiliations

¹ Department of Hematology, Yale University School of Medicine, New Haven, CT. Electronic address: francine.foss@yale.edu.
² Department of Hematology, Yale University School of Medicine, New Haven, CT.
³ Department of Dermatology, Yale University School of Medicine, New Haven, CT.
⁴ Yale University School of Medicine, New Haven, CT.

PMID: 30181105
DOI: 10.1016/j.clml.2018.06.020

No abstract available

Keywords: Leucovorin; Lymphoma; Mucositis; Pralatrexate; Therapy.

PubMed Disclaimer

Similar articles

Clinical remission of primary aggressive CD8+ cutaneous T-cell lymphoma after pralatrexate infusion.
Kerdel FA, Styperek AR, Maini A. Kerdel FA, et al. JAMA Dermatol. 2014 Mar;150(3):320-2. doi: 10.1001/jamadermatol.2013.8647. JAMA Dermatol. 2014. PMID: 24452280 No abstract available.
Methotrexate and Pralatrexate.
Wood GS, Wu J. Wood GS, et al. Dermatol Clin. 2015 Oct;33(4):747-55. doi: 10.1016/j.det.2015.05.009. Epub 2015 Aug 1. Dermatol Clin. 2015. PMID: 26433846 Free PMC article. Review.
Effect of leucovorin administration on mucositis and skin reactions in patients with peripheral T-cell lymphoma or cutaneous T-cell lymphoma treated with pralatrexate.
Foss FM, Parker TL, Girardi M, Li A. Foss FM, et al. Leuk Lymphoma. 2019 Dec;60(12):2927-2930. doi: 10.1080/10428194.2019.1612061. Epub 2019 May 23. Leuk Lymphoma. 2019. PMID: 31119966
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma.
Horwitz SM, Kim YH, Foss F, Zain JM, Myskowski PL, Lechowicz MJ, Fisher DC, Shustov AR, Bartlett NL, Delioukina ML, Koutsoukos T, Saunders ME, O'Connor OA, Duvic M. Horwitz SM, et al. Blood. 2012 May 3;119(18):4115-22. doi: 10.1182/blood-2011-11-390211. Epub 2012 Mar 6. Blood. 2012. PMID: 22394596 Clinical Trial.
Evaluation of the pharmacokinetics, preclinical and clinical efficacy of pralatrexate for the treatment of T-cell lymphoma.
Foss FM. Foss FM. Expert Opin Drug Metab Toxicol. 2011 Sep;7(9):1141-52. doi: 10.1517/17425255.2011.595404. Epub 2011 Jul 5. Expert Opin Drug Metab Toxicol. 2011. PMID: 21726160 Review.

See all similar articles

Cited by

Pralatrexate for refractory mycosis fungoides in two Japanese patients.
Teraishi M, Oguro T, Kusume E, Kobashi H, Sano H, Fujioka A, Yamamoto M, Nakajima H, Sano S. Teraishi M, et al. J Dermatol. 2021 May;48(5):667-671. doi: 10.1111/1346-8138.15761. Epub 2021 Jan 16. J Dermatol. 2021. PMID: 33454985 Free PMC article.
Pralatrexate for Prolonged Treatment of Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified, with Prophylactic Leucovorin.
Kitazume K, Akagawa Y, Wada S, Suzuki T, Fujita A. Kitazume K, et al. Case Rep Oncol. 2019 Jul 16;12(2):529-536. doi: 10.1159/000501070. eCollection 2019 May-Aug. Case Rep Oncol. 2019. PMID: 31427947 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- Genetic Alliance
- MedlinePlus Health Information